Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/22/2010CN101837002A Anti-cancer sustained-release injection
09/22/2010CN101837001A Composition for treating infection and method
09/22/2010CN101837000A Application of 2-fluroin-beta-D-glycoside in treating neuropathic pain
09/22/2010CN101836999A Medicinal composition for curing cardiovascular diseases
09/22/2010CN101836998A Application of tyrosol glucoside in preparing anti-hemorrhagic shock drug
09/22/2010CN101836997A Glycerol/fructose composite and preparation method thereof
09/22/2010CN101836996A Oral solid preparation using loperamide hydrochloride and simethicone as main ingredients
09/22/2010CN101836995A Compound sulfamonomethoxine sodium multivesicular liposome and preparation method thereof
09/22/2010CN101836994A Compound oral preparation of cefaclor and bromhexine and preparation method thereof
09/22/2010CN101836993A Application of 2,3-dihydrogen-3-hydroxymethyl-6-amino-[1,4]-benzoxazine in preparing medicaments for inducing embryonic stem cells to differentiate towards vascular endothelial cells
09/22/2010CN101836992A Application of 4-benzothiopheneaminoquinazoline derivative in preparing tumor treatment medicine
09/22/2010CN101836991A Medicament composition containing sorafenib, cMet inhibitors and EGFR tyrosine kinase inhibitors and application thereof
09/22/2010CN101836990A Application of 4-acetyldiazenequinoline derivative in preparing anti-AIDS drugs
09/22/2010CN101836989A Medicament composition containing tetrandrine, tetrandrine derivatives and histone deacetylase inhibitor and application thereof
09/22/2010CN101836988A Anti-tumor activity of derivative of polyhalogenated isoquinoline imine
09/22/2010CN101836987A Compound niacin sustained release tablet
09/22/2010CN101836986A Dextral-pantoprazole-magnesium-containing pharmaceutical preparation and preparation method thereof
09/22/2010CN101836985A L-pantoprazole magnesium-containing pharmaceutical preparation and preparation method
09/22/2010CN101836984A Dextral-rabeprazole-magnesium-containing pharmaceutical preparation and preparation method thereof
09/22/2010CN101836983A Lansoprazole-containing pharmaceutical preparation and preparation method thereof
09/22/2010CN101836981A Compound valsartan benzenesulfonic acid amlodipine medicament composition and new preparation method thereof
09/22/2010CN101836980A Medical uses of 39-desmethoxyrapamycin and analogues thereof
09/22/2010CN101836979A Medication application of 4-tert-butyl-5-(1,2,4-triazol-1-yl)-2-benzyliminothiazole
09/22/2010CN101836978A Solid preparation containing single crystal form
09/22/2010CN101836976A Application of icaritin in preparation of anti-angiogenic medicaments
09/22/2010CN101836975A Application of isopentene group flavonoid compound used as pancreatic lipase inhibitor
09/22/2010CN101836974A Rivastigmine-hydrogentartrate-containing pharmaceutical composition and preparation method
09/22/2010CN101836973A New application of amide compound
09/22/2010CN101836972A Novel purposes of ferulic acid
09/22/2010CN101836968A Preparation method of effervescent pills
09/22/2010CN101836967A Dihydroartemisinine bilayer tablet and preparation method thereof
09/22/2010CN101836966A Agomelatine-containing orally disintegrating tablet
09/22/2010CN101836965A Orally disintegrating tablet containing fexofenadine or salts of fexofenadine, and preparation method thereof
09/22/2010CN101836964A Antibiotic and use method of control agent for controlling micro organism quantity
09/22/2010CN101836963A Medicinal application preparation for curing hypertension
09/22/2010CN101836962A Method for preparing bendamustine hydrochloride freeze-dried powder injection
09/22/2010CN101836961A Composite drug carried microsphere, minocycline hydrochloride nano controlled-release composite drug carried microsphere system and preparation method thereof
09/22/2010CN101836960A Cefamandole nafate/anhydrous sodium carbonate medicinal composition microsphere injection
09/22/2010CN101836959A Method for preparing almost bitterless rifaximin dry suspension
09/22/2010CN101836958A Preparation of taxane pH sensitive nanoparticles composite for oral administration and application thereof
09/22/2010CN101836957A Ursodeoxycholic acid solid dispersoid, preparation method and solid preparation
09/22/2010CN101836956A Preparation process of fat emulsion injection products and fat emulsion injection products
09/22/2010CN101836955A Hymecromone microemulsion medicament and preparation method thereof
09/22/2010CN101836954A Method for preparing stable xanthophyll-oil suspension
09/22/2010CN101836953A Ambroxol hydrochloride composition injection
09/22/2010CN101836952A Ambroxol injection and preparation method thereof
09/22/2010CN101836951A Ambroxol-hydrochloride-containing oral solution and preparation method thereof
09/22/2010CN101836950A Moxifloxacin hydrochloride glucose injection and preparation method and use thereof
09/22/2010CN101836949A Transcutaneous gel preparation containing antiemetic active medicaments and preparation method thereof
09/22/2010CN101836948A Nitro-brate-containing sustained-release solid preparation
09/22/2010CN101485625B Amoluofen emulsifiable paste
09/22/2010CN101361719B Bromhexine hydrochloric acid orally disintegrating tablet production method
09/22/2010CN101347437B Medicament composition for treating respiratory disease
09/22/2010CN101347436B Uses of methylprednisolone and derivatives thereof in preparing medicament for treating allergic rhinitis
09/22/2010CN101317942B Bone-setting alcohol
09/22/2010CN101317858B Exogenous injury ulcer treating medicine
09/22/2010CN101306074B Anti-alcohol and liver- protection medicine composition
09/22/2010CN101301289B Uses of berberine and analog thereof in pump for reversing multidrug resistance
09/22/2010CN101289516B Hydroxyethyl pachyman sulfuric acid ester and method for preparing same
09/22/2010CN101263830B Multi-effect pesticidal preparations and uses thereof
09/22/2010CN101234094B Dipyridamole orally disintegrating tablet
09/22/2010CN101225066B Cyclohexenone extract of antrodia camphorata
09/22/2010CN101199751B Drug for treating burn, scald and preparing method thereof
09/22/2010CN101181626B Transfer factor capsule and preparation method thereof
09/22/2010CN101180064B Solid pharmaceutical composition with telithromycin
09/22/2010CN101180042B Conjugate of biomacromolecule with bioreductive and preparative method thereof
09/22/2010CN101172103B Medicament for treating multiple diseases such as climacteric syndrome and osteoporosis of women
09/22/2010CN101129335B Use of nano structured lipid carrier drug feeding system
09/22/2010CN101112466B Compound composition for treating chloasma and stimulating evacuation of the bowels and uses thereof
09/22/2010CN101045042B Propofol injection and its preparing method
09/22/2010CN101032479B Ranitidine bismuth citrate medicine and its preparing process
09/22/2010CN101031306B Phosphonate analogs of HIV inhibitor compounds
09/21/2010US7799955 such as 1-(2,4-dimethoxyphenyl)-2-(3,4-methoxyphenyl)-prop-2-en-1-one, used in the prevention of menopausal symptoms, headaches, osteoporosis, rheumatic diseases, atherosclerosis, hypertension, benign prostatic hyperplasia, cancer and inflammatory diseases
09/21/2010US7799954 Dicarbonyl derivatives and methods of use
09/21/2010US7799947 radiolabelled amidine derivatives such as N-(3,5-dichlorobenzyl)-4-iodophenyl amidine suitable for imaging with tomography; selective antagonists of N-methylaspartic acid receptors, used for the diagnosis of pain, epilepsy, stroke, ischemia, spasms, neurodegenerative and psychological disorders
09/21/2010US7799933 4-{[1-(5-Chloro-2-methoxy-benzenesulfonyl)-1H-indole-6-carbonyl]-amino}-phenyl)-acetic acid; inhibiting liver carnitine palmitoyl transferase 1
09/21/2010US7799924 Substituted homopiperidine, piperidine or pyrrolidine derivatives
09/21/2010US7799913 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
09/21/2010US7799909 Hydrophobic starch having near-neutral dry product pH
09/21/2010US7799896 Gene expression inhibition via contacting with tyrphostin; liposomes; drug screening
09/21/2010US7799860 Composition improved in the solubility or oral absorbability
09/21/2010US7799833 System and method for the pretreatment of the endplates of an intervertebral disc
09/21/2010US7799832 Especially tolperisone or its analogs eperisone or silperisone, or riluzole, propafenone, lidocaine, flecainide or metixen or their salts; treating pains which are accompanied by an increase in muscle tone
09/21/2010US7799831 treating gliomas comprising administering protease inhibitors such as 1,2-bis(2-aminophenoxy)ethane, N,N'-di(2-octoxyethyl acetate), N,N'-diacetic acid, with additional therapeutic treatment selected from chemotherapy, radiotherapy, immunotherapy, gene therapy and surgery
09/21/2010US7799830 fewer side-effects by showing no hormone properties; enhancing the learning and memory-retention, treat dementia
09/21/2010US7799829 for the treatment of depression, premenstrual tension, , autism, attention deficit disorder, Tourette's syndrome, post-traumatic stress disorder, dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, spasm, anxiety, drug abuse, urinary incontinence, learning and bipolar disorders
09/21/2010US7799828 selective estrogen receptor modulators such as 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene)methyl]benzoic acid, used for the treatment of osteoporosis, obesity, breast cancer, depression, vaginal dryness, rheumatoid arthritis, vasomotor symptoms and urogenital or vulvar vaginal atrophy
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799826 Treating a cancer in a subject by administering an effective amount of a beta-lactone; inhibiting angiogenesis by administering an inhibitor of fatty acid synthase
09/21/2010US7799825 such as 3-[5-(Trifluoroacetyl)-2-thienyl]benzoic acid, useful as antiproliferative and ancarcinogenic agents, and for treating neurodegenerative diseases, schizophrenia, inflammatory diseases, restenosis, immune disorders, diabetes, cardiovascular disorders, asthma, brain and psychological disorders
09/21/2010US7799824 Quaternary salt CCR2 antagonists
09/21/2010US7799823 Androgen modulators
09/21/2010US7799821 Therapeutic compounds
09/21/2010US7799820 glucokinase activators such as 7-(2-fluorophenoxy)-5-(4-(methylsulfonyl)phenoxy)-2-pyridin-2-yl-1H-indole, used as dietetics and/or antidiabetic agents
09/21/2010US7799819 chronic lymphocytic leukemia or acute lymphoblastic leukemia; use of specific compound (1R)-cyclopropanecarboxylic acid {2-[2-carbamoyl-1-(3-ethoxy-4-methoxy-phenyl)-ethyl]-7-chloro-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
09/21/2010US7799818 Pyrazole derivatives, compositions containing such compounds and methods of use
09/21/2010US7799817 Compositions and methods for sleep regulation
09/21/2010US7799816 N-[2,3-Dibromo-4-(4,5-dihydro-1H-imidazol-2-ylmethyl)-5-fluoro-phenyl]-methanesulfonamide, an alpha-1A adrenergic receptor agonist, used for the treatment of incontinence
09/21/2010US7799815 2-methyl-6-[(1R,5S/1S,5R)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hex-1-yl]quinoline, used to treat drug abuse and dependence, psychological disorders, urogenital disorders or as cognition activators
09/21/2010US7799814 Thiazole derivatives and use thereof
1 ... 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 ... 7860